Polypharmacy is common among multimorbid adults and associated with increased morbidity and mortality. Excessive polypharmacy (ie, ≥10 medicine) is strongly associated with inappropriate medication use, but little is known about attitudes toward deprescribing in patients with excessive polypharmacy. We surveyed 100 Danish individuals aged 65 years and above with ≥10 prescribed medications, using the validated Patients' Attitudes Towards Deprescribing (PATD) instrument. Most participants (81, 81%) thought they took a large number of medications, and 79 (79%) believed that their medications were necessary. Even so, 85 (85%) reported that they would be willing to stop taking one or more of their regular medications if their doctor told them they could, and 11 (11%) felt that they took at least one regular medication that they no longer needed. When presented with visual presentation of various amounts of tablets and capsules, 62 (62%) of participants reported that they would be comfortable taking fewer medications than they did. Forty-two (42%) participants had experience with stopping a regular medication. Almost all participants (92%) wanted to receive follow-up by various means if a medication was discontinued. Forty-one (41%) participants were interested in a consultation at an outpatient clinic specializing in polypharmacy. Overall, the answers to the PATD questionnaire suggest that our cohort of Danish, multimorbid outpatients with extensive polypharmacy have a high confidence in their healthcare providers for medication-related decisions, even though some feel that they are taking more medications than they would like to and feel that some medications may be unnecessary. Our results underline the need for healthcare providers to offer medication reviews in patients with multimorbidity.
| INTRODUCTION
Elderly persons and those with multiple chronic medical conditions such as chronic obstructive lung disease and diabetes are often treated with numerous drugs prescribed by several physicians. 1 Concurrent treatment with several drugs, known as polypharmacy, is costly for society and comprises a risk for medication interactions, adverse effects, hospitalizations, and increased mortality. 2 Excessive or severe polypharmacy (ie ≥10 medicine) is strongly associated with inappropriate medication use 3, 4 and might represents a large pill burden to patients. Results from prior studies indicate that it can be beneficial to decrease the number of medications among multimorbid patients to reduce the risk of medication-related harms. 5, 6 However, few studies have investigated patients' attitudes toward their use of medications and potential withdrawal of prescriptions, ie, deprescribing.
The Patients' Attitudes Towards Deprescribing (PATD) instrument was developed in 2013. 7 Studies based on this questionnaire from Italy 8 and Australia [9] [10] [11] suggest that most hospitalized older patients, 8, 10 outpatients, 9 and nursing home residents 11 think they take a large number of medications and would like to reduce the number of drugs they take on a daily basis. However, patients in these studies generally were not treated with excessive polypharmacy. [7] [8] [9] [10] [11] Thus, in this study we aimed to elucidate the attitudes toward medications and potential deprescribing in a group of elderly outpatients treated with excessive polypharmacy.
| MATERIALS AND METHODS
To examine patients' attitudes toward medications and deprescribing, a structured questionnaire survey was conducted among individuals aged 65 years and above with 10 or more prescribed medications. Participants were recruited from two outpatient clinics 15 Participants were also asked whether they were interested in being contacted for an appointment at an outpatient clinic with a special focus on their medications.
Participants completed the questionnaire, which was distributed and collected by a pharmacist, at the outpatient clinics and could ask the pharmacist questions about the items in the questionnaire. The data collection was stopped when a total of 100 patients had completed the questionnaire.
Information about the number of participants' diagnoses was collected from their electronic patient records from the hospital. Multimorbidity was defined as having two or more of the following chronic conditions: diabetes, cancer, chronic back pain, osteoarthritis, osteoporosis, joint disease, allergies, chronic obstructive pulmonary disease, dementia (excluded from this study), schizophrenia, longterm use of antidepressants, anxiety, high cholesterol, hypertension, stroke, heart disease, and chronic pain. 16 The study was approved by the Danish Data Protection Agency 3 | RESULTS
| Participant characteristics
A total of 63 women and 37 men participated in the survey. Their median age was 75 years (range, 65-92), and 63 (63%) participants had short or no further education. More than half of the participants lived alone (69, 69%). The median number of prescribed medications was 12 (range, 10-32), and all participants had two or more chronic conditions; the median number of conditions was 6 (range, 2-11).
The most prevalent chronic condition was heart disease (87, 87%), hypertension (86, 86%), dyslipidaemia (69, 69%), chronic pain (58, 58%), diabetes (56, 56%), COPD (42, 42%), and osteoporosis (39, 39%). More than half of the participants (59, 59%) rated their health as fair or poor. The major part of the participants (93, 93%) reported that they felt that it was very easy or easy to talk about health issues with healthcare professionals and to follow guidance from healthcare professionals (Table 1) .
| Attitudes toward medications and deprescribing
Most participants (81, 81%) thought they took a large number of medications. Most participants (65, 65%) also reported feeling confident about taking the number of medications they did, and 79 (79%)
believed that their medications were necessary (Table 2) . When responding to visual cues showing certain amounts of tablets or capsules, 62 (62%) participants reported that they would feel comfortable with a maximum of daily intake of eight tablets or capsules (Table 3) . Conversely, 85 (85%) reported that they would be willing to stop taking one or more of their regular medications if their doctor told them they could do so (Table 2 ). Approximately one in ten (11, 11%) felt that they took at least one regular medication that they no longer needed (Table 2 ).
More than two-thirds of participants (71, 71%) reported that it would be acceptable to take even more medications for their conditions. Less than half of participants (40, 40%) believed that one or more of their medications were causing side effects ( Table 2 ). The majority of participants (85, 85%) reported that they had a good understanding of the indication for their medications. For 18 (18%) participants, the cost of medications influenced their willingness to stop taking them (Table 2 ). Less than half of participants (42, 42%)
had experience with stopping one of their regular medications: of these, 16 (38%) reported that they did not need the withdrawed medication, whereas 25 (60%) reported that they had to restart the medication or start a new one (Table 3) .
Asked about what type of follow-up they would prefer if one or more medications were withdrawn, 67 (67%) participants answered that they would want personal contact, and 48 (48%) also wanted to receive written information via post or e-mail. Approximately one in five participants (19, 19%) responded that they preferred to receive follow-up via telephone, and 8 (8%) participants indicated that they wanted no follow-up (Table 3) .
Finally, 41 (41%) participants reported that they would be interested in a consultation in an outpatient clinic focusing on polypharmacy. A similar proportion (42, 42%) reported that they were not interested, 15 (15%) responded that they were unsure about whether they would like a consultation, and 2 (2%) did not respond.
The supplementary tables revealed that there was no association between the participants' attitudes towards medication and deprescribing and self-rated health. Likewise, we found no association between the participants' attitudes toward medication and deprescribing and health literacy. other studies using the PATD questionnaire. 8, 9 Most participants reported that they would like to withdraw one or more of their drugs if their doctor told them that they could do so.
Half of the participants preferred that deprescribing one or more of their drugs would be followed by a consultation with a healthcare professional, and the other half of the participants would have liked post or e-mail follow-up. Less than half of the participants answered that they would be interested in a consultation in a specialised outpatient clinic focusing on polypharmacy. Thus, it seems important that patients trust the healthcare provider who conducts the deprescribing consultation. Other studies have identified trust as a core facet of effective therapeutic relationships, particularly for people with chronic illness because of their greater vulnerability, uncertainty regarding outcomes, and increased dependence on healthcare providers over extended periods of time. 18, 19 Thus, trusting healthcare providers and the healthcare system may be a vital strategy for individuals with chronic illness with many prescribed medications. In addition, sufficient consultation time is essential; limited consultation time results in lower trust in patient-physician relationships. 20 Our results suggest that some patients may prefer to have medication-related issues followed by their general practitioners, whereas others may prefer to be followed by outpatient specialists with whom they have good relationships.
Our results from a Danish outpatient population are consistent with previous studies using the PATD questionnaire among older T A B L E 2 Responses to PATD items 1-10 (n = 100), n (%) (11) 4 (4) 7 (7) 9 (9) 4. If my doctor said it was possible, I would be willing to stop one or more of my regular medications 78 (78) 7 (7) 1 (1) 12 (12) 2 (2) 5. I would like to reduce the number of medications I am taking 74 (74) 8 (8) 2 (2) 11 (11) 3 (3) 6. I feel that I may be taking one or more medications that I no longer need 9 (9) 2 (2) 6 (6) 57 (57) 25 (25) 7. I would accept taking more medications for my health conditions 61 (61) 10 (10) 2 (2) 25 (25) 2 (2) 8. I have a good understanding of the reasons I was prescribed each of my medications 83 (83) 2 (2) 3 (3) 12 (12) 0 (0) 9. The cost of medications impacts my willingness to stop one or more of them 18 (18) 0 (0) 1 (1) 76 (76) 3 (3) 10. I believe one or more of my medications is causing side effects 35 (35) 5 (5) 2 (2) 43 (43) 14 (14) PATD, Patients' Attitudes Towards Deprescribing.
inpatients in Italy and Australia. [9] [10] [11] Galazzi et al. 8 also reported that the majority of study participants felt comfortable with the number of medications they were taking. However, in these studies patients were taking a median of six medications, compared to the median of 12 in our cohort. When using visual cues, the majority of participants in the Italian cohort reported that they would be comfortable taking a maximum of four tablets or capsules per day. This is similar to our findings that visual cues led to a majority of participants reporting that they would be comfortable taking fewer medications than they were.
Limitations of the study entail that the number of study partici- deprescribing., A notion that is supported by the similarity of our result with those of similar studies using PATD in other countries.
In conclusion, our survey suggests that multimorbid outpatients with excessive polypharmacy in Denmark trust their prescribers and feel that their pharmacotherapy is necessary and has very few or no side effects. Paradoxically, many participants would have liked to reduce the number of their medications, and almost half would have liked to be invited to a specialized outpatient clinic focusing on polypharmacy. Our findings emphasis the need for healthcare providers to offer medication reviews and provide systematic follow-up afterward; most patients trust their healthcare providers and cannot be expected to request a medication review.
O R C I D
Michaela L. Schiøtz http://orcid.org/0000-0002-2575-6686
